Chapter 1 provides an overview of chronic obstructive pulmonary disease (COPD), covering its key aspects such as an introduction to COPD, its epidemiology and causes, the underlying pathological mechanisms, diagnostic criteria, and clinical features of the disease.

Chapter 2 focuses on the general treatment of COPD. It discusses the primary groups of drugs used, which include bronchodilators such as methylxanthines, beta2 adrenergic receptor agonists , and antimuscarinic agents. The chapter also covers the use of anti-inflammatory drugs, including corticosteroids, antioxidant drugs, cytokine-targeted drugs, and signaling pathway inhibitors. Additionally, it provides detailed information on the side effects of these drugs and potential interactions between them.

Chapter 3 focuses on the treatment plan based on the GOLD classification, it covers initial treatment strategies, follow-up treatment approaches, and other therapeutic considerations specific to COPD management.